✦ LIBER ✦

Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia

✍ Scribed by Selmin Ataergin; Fikret Arpaci; Turker Cetin; Sefik Guran; Cengiz Yakicier; Murat Beyzadeoglu; Ahmet Ozet

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 81 KB
Volume: 81
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20615

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful allogeneic bone marrow transp

Successful allogeneic bone marrow transplantation after reversion to chronic phase of blast crisis in chronic myeloid leukemia

✍ Dr. J. P. Vernant; M. Rodet; H. Rochant; F. Feuilhade; A. Thuran; P. Bierling; M 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

Donor cell derived acute myeloid leukemi

Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma

✍ Takuya Matsunaga; Kazuyuki Murase; Makoto Yoshida; Akihito Fujimi; Satoshi Iyama 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

Acute myeloid leukemia of donor origin a

Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: Case report and review of the literature

✍ Kaaren K. Reichard; Qian-Yun Zhang; Lorraine Sanchez; John Hozier; David Viswana 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 2 views

Donor cell leukemia: Report of a case oc

Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature

✍ Cooley, Linda D.; Sears, David A.; Udden, Mark M.; Harrison, Wilbur R.; Baker, K 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

We report the case of a man with chronic myelocytic leukemia (CML) and a 46,XY,t(5;9;22) karyotype who developed acute myelocytic leukemia (AML) with a 45,X,t(8;21) karyotype 11 years after bone marrow transplantation (BMT) from his HLA-matched sister. Fluorescent in situ hybridization (FISH) studie

Non-random involvement of chromosome 13

Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia

✍ Andrew Chase; Julie Pickard; Richard Szydlo; Stephanie Coulthard; John M. Goldma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

Chronic myeloid leukemia (CML) patients with persistent or relapsed disease following bone-marrow transplantation (BMT) usually show both clonal and non-clonal cytogenetic changes in addition to the Philadelphia (Ph) translocation. These changes are presumably due to conditioning prior to transplant

Inv (11)(p15q21) in donor-derived Ph-neg

Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation

✍ Bruno C. Medeiros; Kathy Chun; Suzanne Kamel-Reid; Jeffrey Lipton 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

## Abstract Imatinib mesylate (IM) is the standard first‐line treatment for patients with chronic myeloid leukemia (CML). Surprisingly, 2–15% of patients achieving a complete cytogenetic response develop cytogenetic abnormalities in Philadelphia (Ph)‐negative cells. Following hematopoietic stem cel